Philip Gribbon
Dr Philip Gribbon is Head of Discovery Research at the Fraunhofer Institute for Translational Medicine and Pharmacology in Hamburg, Germany and Director General of the European Infrastructure for Chemical Biology, EU-OPENSCREEN. Currently Philip coordinates the IDERHA project which is building an EHDS aligned secure processing environment for analysis of heath data including RWD. Previously, Philip was Chief Scientific Officer of the European ScreeningPort. Previously, Philip has worked at GSK developing new drug discovery and development workflows and at Pfizer covering multiple therapeutic areas. He has a PhD and undergraduate degrees from Imperial College London and Post-doctoral experience from the University of Manchester. Philip is highly engaged in open science initiatives and the application of advanced data analysis methods and has > 120 publications. He has served on the Board of the Society for Laboratory Automation and Screening, including as President in 2025.